一项关于重复性危及生命的血栓形成的研究,伴随着因子IX基因的重复
Xuqian Wei1, Houliang Zhang2, Weibin Chen1
1Department of Clinical Laboratory, Shanghai Jiaotong University Affiliated Sixth People' Hospital, Shanghai, China.
Thrombosis journal
|January 3, 2024
概括
F9基因的遗传重复导致年轻患者的高因子IX (FIX) 活性,导致严重的,危及生命的血栓. 这种遗传性倾向突出了血栓形成的新风险因素.
科学领域:
- 遗传学 遗传学 是一个
- 血液学 血液学 血液学
- 分子生物学分子生物学
背景情况:
- 遗传因素显著影响血栓形成风险,特别是在年轻人中.
- 严重的血栓事件,包括肺动脉,门/介质静脉和下腿动脉血栓形成,构成危及生命的风险.
研究的目的:
- 在一个年轻的患者中调查复发性,严重的血栓事件的遗传基础.
- 识别与增加血栓形成倾向相关的遗传突变或变异.
主要方法:
- 一位患有多次重度血栓发作的年轻患者的综合临床评估.
- 对血液凝结指标的分析和对35个与血栓相关的基因的查.
- 基因测序以确定致病突变,专注于F9基因.
主要成果:
- 发现了X染色体上包含F9基因的756kb复制,导致X因子IX (FIX) 的两个功能副本.
- 患者表现出高FIX活性 (192%),在患者的母亲中发现了类似的重复.
- 在两个人身上观察到高,可变的血FIX水平,以及阳性狼抗凝剂.
结论:
- F9基因复制被强烈认为是患者重复重复的严重血栓事件的原因.
- 由于基因重复而导致的XIX因子活性升高代表了血栓形成的新型遗传风险因素.
- 结合的遗传倾向和狼抗凝剂阳性可能会导致血栓现象型.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
702
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
702
Extrinsic and Intrinsic Pathways of Hemostasis
7.8K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
7.8K
Disorders of Hemostasis
922
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
922
Clot Retraction and Fibrinolysis
6.0K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.0K
Coagulation
6.7K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
6.7K
Genome-wide Association Studies-GWAS
13.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.4K


